The remarkable beneficial effect of adding oral simvastatin to topical betamethasone for treatment of psoriasis: a double-blind, randomized, placebo-controlled study.

Nigerian journal of medicine : journal of the National Association of Resident Doctors of Nigeria

Volumn 19, Issue 1, 2010, Pages 58-61

  Naseri, M ^a   Hadipour, A ^a   Sepaskhah, M ^a   Namazi, M R ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; BETAMETHASONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SIMVASTATIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION; DRUG COMBINATION; FEMALE; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PATHOLOGY; PSORIASIS; RANDOMIZED CONTROLLED TRIAL; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; AGED; ANTI-INFLAMMATORY AGENTS; BETAMETHASONE; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; PSORIASIS; SEVERITY OF ILLNESS INDEX; SIMVASTATIN; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77950498561     PISSN: 11152613     EISSN: None     Source Type: Journal    
DOI: 10.4314/njm.v19i1.54216     Document Type: Article

References (0)